Home

Xenoblis is a specialized CRO in ADME studies using ex vivo, in vitro and in silico techniques.

Xenoblis is proficient in metabolism, DDI (induction, inhibition and phenotyping), protein binding, uptake and efflux, hepatotoxicity studies, relying on a dedicated team of experienced scientists/study directors and state of the art equipment and premices. Xenoblis would be pleased to contribute successfully to your drug development projects.

This web site will hopefully allow you the opportunity to learn more about us and to request information and/or proposals.